drugset / Trial / NCT03848832
Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy of cannabidiol oral solution (GWP42003-P, CBD-OS) in reducing symptom severity when compared with placebo, in participants with Rett syndrome.
Timeline
- Start
- 2019-07-29
- Primary completion
- 2021-01-21
- Completion
- 2021-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 5 mg/kg | Oral |
| Subject | Cannabidiol | Other / unclassified | 15 mg/kg | Oral |